SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-002223
Filing Date
2018-01-04
Accepted
2018-01-04 08:05:04
Documents
4
Period of Report
2017-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d501784d8k.htm 8-K 23949
2 EX-5.1 d501784dex51.htm EX-5.1 9872
3 EX-10.1 d501784dex101.htm EX-10.1 162965
4 GRAPHIC g501784g1230102649794.jpg GRAPHIC 3392
  Complete submission text file 0001193125-18-002223.txt   203035
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-769-9145
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 18508428
SIC: 2834 Pharmaceutical Preparations